Cipla: Domestic market blues... - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cipla: Domestic market blues...

Apr 28, 2003

Domestic pharma major, Cipla Ltd, has posted disappointing March numbers. The company has reported a marginal 2% dip in income from operations, but net profits shrunk by over 24% during the quarter. The company's operating margins nearly halved to just over 12% in 4QFY03.

(Rs m)4QFY024QFY03ChangeFY02FY03Change
Net Sales3,9433,882-1.6%14,00515,72412.3%
Other Income21111440.0%284258-9.0%
Expenditure3,0553,41111.7%10,96112,56114.6%
Operating Profit (EBDIT)888471-47.0%3,0443,1643.9%
Operating Profit Margin (%)22.5%12.1%21.7%20.1%
Interest 5976.0%2116-22.4%
Depreciation7267-6.7%21328333.1%
Profit before Tax832506-39.2%3,0943,1220.9%
Tax21538-82.1%743648-12.8%
Profit after Tax/(Loss)617467-24.3%2,3512,4755.3%
Net profit margin (%)15.7%12.0%16.8%15.7%
No. of Shares 60.060.060.060.0
Diluted Earnings per share*41.231.239.241.3
P/E Ratio15.4
*(annualised)

The company's domestic sales fell by 10% during the quarter (to about Rs 2 bn). The management seems to have attributed this to the slower domestic industry growth (about 2%-3%) during the quarter and also to the VAT worries owing to which stockists put off purchases until further clarity emerged on the issue. However, the dip in domestic sales was compensated by a 9% growth in export sales (to over Rs 1.9 bn). The export sales growth is very encouraging. The operating margin plummeted consequent to the flattish sales growth.

In FY03, the company finished with just over 12% topline growth, with a marginal operating margin decline (can be attributed to the poor March quarter margins). Cipla managed to grow its bottomline by a staid 5% during the year. This growth was possible only because of a 12% dip in tax provisions, which came about owing to the tax benefits of the new Goa plant.

Cost snapshot
(Rs m)4QFY024QFY03ChangeFY02FY03Change
(Increase)/decrease in stock in trade-444-249--851-787-
Raw material cost2,0022,23511.6%6,9087,96815.4%
Staff cost1781917.2%63372915.2%
Other expenses1,3181,234-6.4%4,2724,6518.9%
Total expenditure3,0553,41111.7%10,96112,56114.6%

The stock tanked today and touched new 52-week lows of Rs 565. Currently, at Rs 634 the stock trades at 15.4x FY03 earnings. We believe that the long term prospects of the company are good and are encouraged by the continuing export growth. However, the slowdown in the domestic markets is a cause for concern and may temper sentiment in the short term.

Equitymaster requests your view! Post a comment on "Cipla: Domestic market blues...". Click here!

  

More Views on News

Cipla's New Covid-19 Drug to Be Sold at Rs 59,750 Per Dose (Views On News)

May 25, 2021

The first batch of Roche's antibody cocktail has been launched in India, with the second batch to be made available by mid-June.

Cipla's Q4 Update: Net Profit Surges 68%; Company to Pay Rs 5 Dividend (Views On News)

May 17, 2021

Here's a rundown on the latest quarterly results of Cipla.

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Points to Keep in Mind Before Subscribing to Krishna Institute of Medical Sciences' IPO (Views On News)

Jun 15, 2021

All you need to know about the IPO of Krishna Institute of Medical Sciences.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments (Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

The Most Visible Sign of India's Revival is on Two Wheels (Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth (Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Jun 18, 2021 (Close)

TRACK CIPLA

CIPLA - MYLAN COMPARISON

COMPARE CIPLA WITH

MARKET STATS